Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Aberrant DNA methylation of hypothalamic angiotensin receptor in prenatal programmed hypertension
Fumiko Kawakami-Mori, … , Takeshi Marumo, Toshiro Fujita
Fumiko Kawakami-Mori, … , Takeshi Marumo, Toshiro Fujita
Published November 2, 2018
Citation Information: JCI Insight. 2018;3(21):e95625. https://doi.org/10.1172/jci.insight.95625.
View: Text | PDF
Research Article Development

Aberrant DNA methylation of hypothalamic angiotensin receptor in prenatal programmed hypertension

  • Text
  • PDF
Abstract

Maternal malnutrition, which causes prenatal exposure to excessive glucocorticoid, induces adverse metabolic programming, leading to hypertension in offspring. In offspring of pregnant rats receiving a low-protein diet or dexamethasone, a synthetic glucocorticoid, mRNA expression of angiotensin receptor type 1a (Agtr1a) in the paraventricular nucleus (PVN) of the hypothalamus was upregulated, concurrent with reduced expression of DNA methyltransferase 3a (Dnmt3a), reduced binding of DNMT3a to the Agtr1a gene, and DNA demethylation. Salt loading increased BP in both types of offspring, suggesting that elevated hypothalamic Agtr1a expression is epigenetically modulated by excessive glucocorticoid and leads to adult-onset salt-sensitive hypertension. Consistent with this, dexamethasone treatment of PVN cells upregulated Agtr1a, while downregulating Dnmt3a, and decreased DNMT3a binding and DNA demethylation at the Agtr1a locus. In addition, Dnmt3a knockdown upregulated Agtr1a independently of dexamethasone. Hypothalamic neuron–specific Dnmt3a-deficient mice exhibited upregulation of Agtr1a in the PVN and salt-induced BP elevation without dexamethasone treatment. By contrast, dexamethasone-treated Agtr1a-deficient mice failed to show salt-induced BP elevation, despite reduced expression of Dnmt3a. Thus, epigenetic modulation of hypothalamic angiotensin signaling contributes to salt-sensitive hypertension induced by prenatal glucocorticoid excess in offspring of mothers that are malnourished during pregnancy.

Authors

Fumiko Kawakami-Mori, Mitsuhiro Nishimoto, Latapati Reheman, Wakako Kawarazaki, Nobuhiro Ayuzawa, Kohei Ueda, Daigoro Hirohama, Daisuke Kohno, Shigeyoshi Oba, Tatsuo Shimosawa, Takeshi Marumo, Toshiro Fujita

×

Figure 3

Offspring of pregnant rats treated with dexamethasone (Dex).

Options: View larger image (or click on image) Download as PowerPoint
Offspring of pregnant rats treated with dexamethasone (Dex).
(A) Levels ...
(A) Levels of Dnmt1 (n = 7) and Dnmt3a (n = 11) mRNA in control and Dex-treated offspring, and levels of Agtr1a and Agtr1b mRNA in control (n = 13 and 9, respectively) and Dex-treated (n = 9 and 6, respectively) offspring. (B) Bisulfite sequence analysis of the Agtr1a locus in the PVN from 12-week-old control and Dex-treated offspring. Top, schematic diagram of the Agtr1a locus. Dashes and numbers indicate the positions of the cytosine residues of CpG dinucleotides relative to the TSS (+1). Bottom, DNA methylation status of the CpG sites between +114 and +214 bp relative to the TSS. Filled circles, methylated CpG sites; open circles, demethylated CpG sites. (C) ChIP assays showing DNMT1 (top) and DNMT3a (bottom) binding to the sites –97 to +107 (n = 6 and 8 for DNMT1, and n = 9 and 11 for DNMT3a, respectively) and +174 to +366 relative to the TSS (n = 4 and 4 in DNMT1, and n = 10 and 8 in DNMT3a, respectively), in the PVN of control and Dex-treated offspring. Filled circles, control; open circles, Dex-treated offspring. Throughout, data represent the means ± SEM. *P < 0.05 versus control offspring (t test).

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts